DUBLIN–(BUSINESS WIRE)–The “Global Insulin Syringes Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
The insulin syringes market is poised to grow by $ 408.67 mn during 2022-2026, accelerating at a CAGR of 4.69% during the forecast period. The report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, favorable government initiatives, and the availability of diabetes self-management education programs.
The insulin syringes market analysis includes type segment and geographic landscape.
The insulin syringes market is segmented as below:
By Type
Type 2 diabetes
Type 1 diabetes
By Geographical Landscape
North America
Europe
APAC
South America
Middle East and Africa
This study identifies the increase in awareness programs for diabetes as one of the prime reasons driving the insulin syringes market growth during the next few years. Also, rising strategic partnerships to boost sales of insulin syringes and increasing focus on smart insulin syringes will lead to sizable demand in the market.
The report on the insulin syringes market covers the following areas:
Insulin syringes market sizing
Insulin syringes market forecast
Insulin syringes market industry analysis
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Disease Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Companies Mentioned
AdvaCare Pharma
ASP Healthcare Pty Ltd.
Avantor Inc.
B. Braun SE
Becton Dickinson and Co.
Cardinal Health Inc
CODAN Medizinische Gerate GmbH and Co KG
Gerresheimer AG
Healthwarehouse.com Inc.
Hi-Tech Medics Pvt Ltd.
Hindustan Syringes and Medical Devices Ltd.
LAC Healthcare Solutions
Nipro Corp.
Novo Nordisk AS
Poly Medicure Ltd.
SCHOTT AG
Smiths Group Plc
Terumo Corp.
Thermo Fisher Scientific Inc.
UltiMed Inc.
For more information about this report visit https://www.researchandmarkets.com/r/7q02ku
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
